中财网 中财网股票行情
川宁生物(301301)财务分析指标    年份：
截止日期2025-12-312025-09-302025-06-302025-03-312024-12-31
营业总收入(万元)461626.96343598.43234858.40129694.96575830.77
营业收入(万元)461626.96343598.43234858.40129694.96575830.77
营业总成本(万元)367504.96268180.53178226.3094949.47407014.38
营业成本(万元)326595.67230897.69150626.4181275.61366309.21
净利润(万元)76929.8861139.3245485.8328821.85140022.48
归属于母公司的净利润(万元)76900.8961139.3245485.8328821.85140032.41
营业利润(万元)95698.7976793.6257543.1235333.18168776.29
利润总额(万元)93868.5875177.4855950.3235000.27167509.18
少数股东损益(万元)-66.27-48.92-28.26-1.192.61
基本每股收益(元)0.34(元)0.27(元)0.20(元)0.13(元)0.63(元)
稀释每股收益(元)0.34(元)0.27(元)0.20(元)0.13(元)0.63(元)
非经常性损益(万元)1080.11340.79-158.35517.97190.52
扣除非经常性损益后净利润(万元)75820.7860798.5245644.1828303.89139841.90
总资产(万元)1042948.031033077.771015930.431073254.331055358.00
总负债(万元)232164.75237926.77237232.34252534.62263716.41
归属于母公司股东权益合计(万元)808246.68792597.03776843.47818838.02789758.70
股东权益合计(万元)810783.28795151.00778698.09820719.71791641.58
实收资本(股本)(万元)223008.50223008.50223008.50222716.00222716.00
资本公积(万元)329826.32329967.25329867.17328684.92328427.46
未分配利润(万元)213639.67207099.31191445.82234915.12206093.27
经营活动产生的现金流量净额(万元)54905.9557094.1339148.3811658.45179106.73
经营活动现金流入小计(万元)348692.81282725.41165289.4464816.35478311.20
经营活动现金流出小计(万元)293786.86225631.28126141.0653157.89299204.47
投资活动产生的现金流量净额(万元)-23193.21-30197.20-4499.95-22250.15-10621.72
投资活动现金流入小计(万元)279103.88192203.0596156.4620046.4420618.41
投资活动现金流出小计(万元)302297.09222400.25100656.4142296.5931240.14
筹资活动产生的现金流量净额(万元)-67391.58-60905.48-62675.74-2875.14-136106.92
筹资活动现金流入小计(万元)76812.6052012.541293.550.0080619.19
筹资活动现金流出小计(万元)144204.18112918.0163969.292875.14216726.11
期末现金及现金等价物余额(万元)73421.3374758.4880833.4895264.14108833.17
最后修改日期2026-03-312025-10-282025-08-262025-04-292025-04-22
↑返回页顶↑

转至川宁生物（301301）行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料，仅供用户获取信息。